Drug Manufacturer Interested in Presenting at P&T

Drug manufacturers whose products are under review by the Ohio Department of Medicaid (ODM) P&T Committee may request the opportunity to present clinical information at the meeting during which their product is reviewed. Any presentation by a drug manufacturer should focus on the relative clinical merits of their drug versus a comparable product. Please note that price should not be discussed with P&T Committee members.

To request a presentation, email speaker contact information along with what product will be presented to the ODM clinical vendor mailbox at no later than the Friday before the meeting.*

Please note:

  1. Presentations will be limited to a maximum of five minutes, with the Committee chair having the option to extend or limit the time depending upon the situation
  2. The presenter should provide 12 hard copies of any presentation to the Committee members

*For the Annual UPDL review, which takes place in the 4th Quarter of each year, drug manufacturers should refer to the information available at to identify when and how they should request to present. This meeting will have an earlier cut-off date, at least four weeks prior to the meeting. Note, when the notice becomes available it will appear at the top of the home page; otherwise, the notice is not yet available.